Showing results (11-20 of 499) with videos related to
Sort By:
Pageof 50
Health Affairs (Project Hope)|November 1, 2021
Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial MedicinesKevin OuttersonThe Milbank Quarterly|September 22, 2011
An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequencesAaron S KesselheimThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|March 4, 2024
Government Support of Meaningful Drug and Device Innovation: Pathways and ChallengesAaron S KesselheimThe AAPS Journal|October 6, 2007
Intellectual property policy in the pharmaceutical sciences: the effect of inappropriate patents and market exclusivity extensions on the health care systemAaron S KesselheimHealth Affairs (Project Hope)|May 4, 2016
Funding Antibiotic Innovation With Vouchers: Recommendations On How To Strengthen A Flawed Incentive PolicyKevin Outterson, Anthony McDonnellThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|December 20, 2021
Over-the-Counter Monograph Safety, Innovation, and Reform ActJason Gardiner, Aaron S KesselheimThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|June 5, 2009
Using patent data to assess the value of pharmaceutical innovationAaron S Kesselheim, Jerry AvornClinical Pharmacology and Therapeutics|March 28, 2025
Frequency and Nature of Generic "Design Around" of Brand-Name Patents in the United StatesJanet Freilich, Aaron S KesselheimHealth Affairs (Project Hope)|May 4, 2016
'Government Patent Use': A Legal Approach To Reducing Drug SpendingAmy Kapczynski, Aaron S KesselheimPageof 50